Free Trial

Best Medical Stocks To Add to Your Watchlist - November 16th

Stryker logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Stryker, Boston Scientific, and McKesson were identified as medical stocks to watch because they had the sector’s highest dollar trading volume in recent days. Their businesses span medical technology and devices, and healthcare and pharmaceutical distribution.
  • In Monday trading, Stryker rose $1.61 to $311.25 and McKesson gained $3.67 to $1,106.48, while Boston Scientific slipped $0.36 to $43.98.
  • The stocks showed differing recent trends: Stryker and Boston Scientific traded above their 50-day moving averages but below their 200-day averages, while McKesson traded above both.
  • Interested in Stryker? Here are five stocks we like better.

Stryker, Boston Scientific, and McKesson are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies involved in healthcare, such as pharmaceutical and biotech firms, medical-device makers, and healthcare providers. Their performance can be affected by factors including research results, regulation, patent protection, and demand for medical services and products. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Stryker (SYK)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Shares of NYSE SYK traded up $1.61 during trading on Monday, hitting $311.25. The company had a trading volume of 1,041,758 shares, compared to its average volume of 2,514,251. The stock has a 50 day simple moving average of $292.30 and a 200 day simple moving average of $322.60. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.30 and a current ratio of 2.18. Stryker has a 12 month low of $267.00 and a 12 month high of $389.33. The firm has a market capitalization of $118.49 billion, a P/E ratio of 33.16, a price-to-earnings-growth ratio of 2.13 and a beta of 0.78.

Read Our Latest Research Report on SYK

Boston Scientific (BSX)

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system.

Shares of NYSE:BSX traded down $0.36 during mid-day trading on Monday, reaching $43.98. 5,752,838 shares of the company traded hands, compared to its average volume of 18,662,734. The company's 50 day moving average price is $44.00 and its 200-day moving average price is $54.50. The firm has a market cap of $63.75 billion, a PE ratio of 18.66, a PEG ratio of 1.31 and a beta of 0.60. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.36 and a quick ratio of 0.81. Boston Scientific has a 52 week low of $39.57 and a 52 week high of $102.71.

Read Our Latest Research Report on BSX

McKesson (MCK)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

NYSE MCK traded up $3.67 on Monday, reaching $1,106.48. 222,209 shares of the stock were exchanged, compared to its average volume of 907,480. McKesson has a one year low of $723.68 and a one year high of $1,121.50. The firm has a market capitalization of $127.75 billion, a PE ratio of 28.41, a PEG ratio of 1.86 and a beta of 0.27. The company's 50-day simple moving average is $955.45 and its two-hundred day simple moving average is $874.53.

Read Our Latest Research Report on MCK

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Stryker Right Now?

Before you consider Stryker, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stryker wasn't on the list.

While Stryker currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines